Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10145679 | 0.84 | CYP3A4 (0.43) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10145626 | 0.74 | CYP3A4 (0.65) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL15143761 | 0.72 | CYP3A4 (0.56) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL15143759 | 0.71 | FTO (0.61) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10145657 | 0.69 | CYP3A4 (0.60) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL15145557 | 0.69 | MAPT (0.70) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10145671 | 0.69 | FTO (0.48) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10145674 | 0.68 | CYP3A4 (0.41) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10175861 | 0.68 | CYP3A4 (0.58) | CYP3A4MEN1USP2ALDH1A1LMNA | |
| SCHEMBL10145651 | 0.67 | CYP3A4 (0.56) | CYP3A4MEN1USP2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114904-B2 | Luminescence quenchers and fluorogenic probes for detection of reactive species | Versitech Limited & Morningside Ventures Limited (CN) | 2012-02-14 | — | — | US | disclosed |
| US-8114904-B2 | Luminescence quenchers and fluorogenic probes for detection of reactive species | Versitech Limited & Morningside Ventures Limited (CN) | 2012-02-14 | — | — | US | disclosed |
| US-20090253118-A1 | LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES | VERSITECH LIMITED (CN) | 2009-10-08 | — | — | US | disclosed |
| US-20090253118-A1 | LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES | VERSITECH LIMITED (CN) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253118-A1 | LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES | ROS1, LPO, HMOX1 | CYP3A4 508/4885MEN1 4478/4885USP2 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.